Welcome to ASCAT 2026

7-10 October, Central Hall Westminster, London

On behalf of the Academy for Sickle Cell and Thalassaemia (ASCAT), it is my great pleasure to welcome you to the 21st Annual Sickle Cell & Thalassaemia Conference, delivered in continued collaboration with the European Hematology Association (EHA). ASCAT 2026 marks the first chapter of our new multi-year conference series, Haemoglobinopathies Without Borders, beginning with Building Care That Lasts: Sustainability in Haemoglobinopathy Care.

This year’s programme focuses on the practical realities of delivering equitable, high-quality care across regions, systems and generations – examining how scientific progress, workforce development, policy, advocacy and emerging therapies can be translated into durable models of care worldwide. Through cutting-edge research, applied sessions, and meaningful collaboration, ASCAT 2026 brings together clinicians, scientists, patients, advocates and partners to address shared challenges and help shape a more sustainable and equitable future for all those affected by sickle cell disease and thalassaemia.

Professor Biree Andemariam
Scientific Programme Chair